Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 366   Home Print this page  Email this page Small font size Default font size Increase font size
  Feedback 
 Back To Article

  Reader Comments

Year : 2017 | Volume:  9 | Issue Number:  3

ORIGINAL ARTICLE

The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study

Tanuma Yasushi, Tanaka Yoshinori, Takeyama Ko, Okamoto Tomoshi

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks